"10.1371_journal.pone.0089374","plos one","2014-02-24T00:00:00Z","Tina Kiffer-Moreira; Campbell R Sheen; Kellen Cristina da Silva Gasque; Mayte Bolean; Pietro Ciancaglini; Andrea van Elsas; Marc F Hoylaerts; José Luis Millán","Sanford Childrens Health Research Center, Sanford-Burnham Medical Research Institute, La Jolla, California, United States of America; Departamento de Química, FFCLRP-USP, Ribeirão Preto, São Paulo, Brazil; AM-Pharma BV, Bunnik, The Netherlands; Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium.","¶ MFH and JLM are joint senior authors on this work.","Dr. Andrea van Elsas, co-author of this paper, is VP of Research of AM Pharma, a company that is now manufacturing the ChimAP described in this paper and conducting clinical trials with this novel protein therapeutic. This study was funded in part by AM Pharma. The authors have the following patent/patent applications relating to material pertinent to this article: Australia: 2008244716, China: ZL 2008 80017810.0, Japan: 5320387, US: 8,557,545, Canada: 2,685,405, Europe: 08741670.7, all entitled: Modified Phosphatases. The authors have declared their adherence to all the PLoS ONE policies on sharing data and materials.","2014","02","Tina Kiffer-Moreira","TKM",8,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
